Tag Archives: parallel importing

Parallel importing and exporting of pharmaceuticals severely limits the options in designing an effective UK drug pricing scheme.

Posted on November 15, 2011 by Barbara Arzymanow

A fundamental principle of the EU is the establishment of a single market where products can be freely imported and exported between member states. In the case of pharmaceuticals this ideal conflicts with the freedom of individual countries to fix … Continue reading →

Posted in Business, competition, Department of Health, Drugs, Innovation, NHS, Pharma, Policy, Research | Tagged , , , , , , , , , , , , , , , , , , , , , | 1 Comment